Study guide
17.4 Patient Safety Science, Medical Error & Diagnostic Reasoning
ABIM Internal Medicine Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 0: The ABIM Exam, Blueprint & Study Strategy
0.1 Exam Format, Question Types & the 2026 Blueprint 0.2 Eligibility, Registration, Fees & Exam-Day Logistics 0.3 Scoring, the Passing Standard & Score Reports 0.4 Building a Blueprint-Weighted Study Plan
2 Chapter 1: Cardiovascular Disease (14% of Exam)
1.1 Ischemic Heart Disease & Acute Coronary Syndromes 1.2 Antithrombotic Therapy, Secondary Prevention & Mechanical Complications of MI 1.3 Atrial Fibrillation, Atrial Flutter & Stroke Prevention 1.4 Supraventricular Tachycardias, Ventricular Arrhythmias & Bradycardias 1.5 Heart Failure: Classification, Staging & Guideline-Directed Medical Therapy 1.6 Device Therapy, HFpEF & the Cardiomyopathies 1.7 Valvular Heart Disease & Endocarditis Prophylaxis 1.8 Pericardial Disease & Acute Aortic Syndromes 1.9 Hypertension: Classification, Diagnosis & Secondary Causes 1.10 Hypertensive Crises & Dyslipidemia 1.11 Adult Congenital Heart Disease & Coarctation of the Aorta 1.12 Syncope: Reflex, Orthostatic & Cardiac Causes 1.13 Cardiac Physical Examination, Murmurs & Antithrombotic Selection
3 Chapter 2: Endocrinology, Diabetes & Metabolism (9% of Exam)
2.1 Diabetes Mellitus: Diagnosis, Glycemic Targets & Pharmacotherapy 2.2 Insulin Therapy, Hyperglycemic Emergencies & Chronic Complications 2.3 Thyroid Function Testing & Hypothyroidism 2.4 Thyrotoxicosis, Thyroid Storm & Thyroid Nodules 2.5 Adrenal & Pituitary Disorders 2.6 Hypercalcemia, Hypocalcemia & Disorders of Mineral Metabolism 2.7 Osteoporosis & Paget Disease of Bone 2.8 Ovarian, Testicular & Reproductive Endocrine Disorders 2.9 Hypoglycemia, Endocrine Tumors, Polyglandular Syndromes & Severe Hypertriglyceridemia
4 Chapter 3: Gastroenterology & Hepatology (9% of Exam)
3.1 Esophageal Disease 3.2 Stomach & Duodenal Disease and Gastrointestinal Hemorrhage 3.3 Inflammatory Bowel Disease 3.4 Celiac Disease & Irritable Bowel Syndrome 3.5 Diverticular Disease & Colorectal Cancer Screening 3.6 Viral Hepatitis, Steatotic & Alcohol-Associated Liver Disease 3.7 Cirrhosis & the Complications of Portal Hypertension 3.8 Acute Pancreatitis 3.9 Chronic Pancreatitis & Biliary Tract Disease 3.10 Inherited, Autoimmune & Drug-Induced Liver Disease 3.11 Small Intestinal Disease, Ischemia & Gastrointestinal Complications of HIV
5 Chapter 4: Infectious Disease (9% of Exam)
4.1 Lower Respiratory Tract Infections & Sepsis Syndromes 4.2 Viral Respiratory Pathogens & Tuberculosis 4.3 Central Nervous System Infections 4.4 Skin, Soft Tissue, Bone & Joint Infections 4.5 Infective Endocarditis & Cardiovascular Infection 4.6 Clostridioides difficile & Catheter-Related Bloodstream Infection 4.7 HIV Diagnosis, Antiretroviral Therapy & Prevention 4.8 Opportunistic Infections & Sexually Transmitted Infections 4.9 Fever of Unknown Origin, Neutropenic Fever & Toxic Shock 4.10 Travel-Related Illness, Vector-Borne Disease & Outbreaks 4.11 Infection Prevention, Nosocomial Infection & Postexposure Prophylaxis 4.12 Rheumatic Fever, Poststreptococcal Disease, Enteric & Hepatic Infections
6 Chapter 5: Pulmonary Disease (9% of Exam)
5.1 COPD: Diagnosis, GOLD Classification & Initial Pharmacotherapy 5.2 Interventions That Reduce COPD Mortality & Exacerbation Management 5.3 Asthma: Diagnosis, Stepwise Therapy & Status Asthmaticus 5.4 Interstitial Lung Disease & Idiopathic Pulmonary Fibrosis 5.5 Sarcoidosis, Hypersensitivity Pneumonitis & Occupational Lung Disease 5.6 Pulmonary Embolism: Diagnosis, Risk Stratification & Anticoagulation 5.7 Pulmonary Hypertension & Sleep-Disordered Breathing 5.8 Acute Respiratory Distress Syndrome & Mechanical Ventilation 5.9 Pleural Disease, Empyema & Pneumothorax 5.10 Bronchiectasis, Cystic Fibrosis & Restrictive Lung Disease 5.11 Evaluation of Cough, Dyspnea, Hemoptysis & the Solitary Pulmonary Nodule
7 Chapter 6: Rheumatology & Orthopedics (9% of Exam)
6.1 Rheumatoid Arthritis: Diagnosis & Systemic Manifestations 6.2 Antirheumatic Pharmacotherapy & the Spondyloarthropathies 6.3 Gout: Pathophysiology & Acute Management 6.4 Urate-Lowering Therapy & Calcium Pyrophosphate Deposition Disease 6.5 Osteoarthritis 6.6 Systemic Lupus Erythematosus 6.7 Systemic Sclerosis, Sjogren Syndrome & Inflammatory Myopathies 6.8 The Vasculitides 6.9 Regional Musculoskeletal Syndromes, Back Pain & Sports Injuries 6.10 Other Primary Rheumatic Disorders & Mixed Connective Tissue Disease 6.11 Osteonecrosis & Metabolic Bone Disease
8 Chapter 7: Hematology (6% of Exam)
7.1 Approach to Anemia & the Microcytic Anemias 7.2 Macrocytic, Normocytic & Hemolytic Anemias 7.3 Hemoglobinopathies, Thalassemias & Paroxysmal Nocturnal Hemoglobinuria 7.4 Platelet Disorders, Thrombocytopenia & the Bleeding Patient 7.5 Coagulation Factor Disorders, Thrombophilia & Anticoagulant Reversal 7.6 Acute Leukemias, Chronic Leukemias & Myeloproliferative Neoplasms 7.7 Lymphomas & Plasma Cell Disorders 7.8 Myelodysplastic Syndrome, Myeloproliferative Neoplasms & Porphyria 7.9 Transfusion Medicine & Late Complications of Transplantation
9 Chapter 8: Medical Oncology (6% of Exam)
8.1 Breast, Lung, Colorectal & Prostate Cancer 8.2 Oncologic Emergencies 8.3 Genitourinary & Gynecologic Malignancies 8.4 Head and Neck, Bone & Soft Tissue Cancer and Cancer of Unknown Primary 8.5 Complications of Cancer & Its Treatment 8.6 Cancer Prevention, Survivorship & Psychosocial Care
10 Chapter 9: Nephrology & Urology (6% of Exam)
9.1 Acute Kidney Injury: Staging, Etiology & Urine Microscopy 9.2 Glomerular Disorders & Nephrotic Syndrome 9.3 Nephritic Syndromes, RPGN & Indications for Renal Replacement Therapy 9.4 Chronic Kidney Disease: Staging & Progression Retardation 9.5 Complications of Chronic Kidney Disease: Anemia, CKD-MBD & Acidosis 9.6 Hyponatremia, Hypernatremia & Water Balance 9.7 Potassium Disorders & Systematic Acid-Base Analysis 9.8 Renal Tubular Acidosis & Nephrolithiasis 9.9 Prostate Disorders, Urinary Incontinence & Other Urologic Conditions 9.10 Cystic Kidney Disease, Obstructive Uropathy, Tubulointerstitial Disease & Hematuria
11 Chapter 10: Neurology (4% of Exam)
10.1 Acute Ischemic Stroke: Syndromes & Reperfusion 10.2 Transient Ischemic Attack, Secondary Prevention & Hemorrhagic Stroke 10.3 Headache & Facial Pain 10.4 Seizures, Epilepsy & Movement Disorders 10.5 Multiple Sclerosis & Neuromuscular Junction Disorders 10.6 Motor Neuron Disease & Acute Peripheral Neuropathy 10.7 Cranial Neuropathies & Neuro-Ophthalmology 10.8 Peripheral Neuropathies, CNS Tumors & Other Neurologic Disorders
12 Chapter 11: Psychiatry & Behavioral Health (4% of Exam)
11.1 Major Depressive Disorder & Medical Mimics 11.2 Antidepressant Pharmacotherapy & Treatment-Resistant Depression 11.3 Bipolar Disorder, Mood Stabilizers & Lithium Toxicity 11.4 Anxiety, Stress-Related & Obsessive-Compulsive Disorders 11.5 Alcohol Use Disorder & Withdrawal 11.6 Pharmacotherapy for Alcohol & Opioid Use Disorder 11.7 Toxidromes, Psychiatric Emergencies & Suicide Risk Assessment 11.8 Psychotic, Somatic Symptom, Factitious & Personality Disorders 11.9 Eating Disorders, Sleep Disorders & Sexual Health
13 Chapter 12: Dermatology (3% of Exam)
12.1 Dermatitis, Papulosquamous & Inflammatory Dermatoses 12.2 Acne, Rosacea & Cutaneous Infections 12.3 Herpes Zoster & Autoimmune Blistering Diseases 12.4 Nodules, Tumors & Cutaneous Oncology 12.5 Dermatologic Emergencies & Severe Cutaneous Adverse Reactions 12.6 Pigment Disorders, Alopecia, Nail Disease & Photosensitivity 12.7 Vascular Dermatoses, Environmental Injury & Cutaneous Signs of Systemic Disease
14 Chapter 13: Obstetrics & Gynecology / Women's Health (3% of Exam)
13.1 Contraception, Preconception Care & Teratogenicity 13.2 Hypertensive Disorders of Pregnancy & Gestational Diabetes 13.3 Thyroid Disease & Venous Thromboembolism in Pregnancy 13.4 Menopause & Menopausal Hormone Therapy 13.5 Abnormal Uterine Bleeding, Endometrial Disease & Gynecologic Cancer Screening 13.6 Breast Disorders & Diseases of the Vulva and Vagina 13.7 Menstrual Disorders, Fibroids, Endometriosis & Early Pregnancy Complications
15 Chapter 14: Geriatric Syndromes (3% of Exam)
14.1 Comprehensive Geriatric Assessment & Frailty 14.2 Falls, Gait Assessment & Polypharmacy 14.3 Urinary Incontinence & Pressure Injuries in Older Adults 14.4 Mild Cognitive Impairment, Dementia & Its Subtypes 14.5 Delirium & the Pharmacotherapy of Cognitive Disorders 14.6 Palliative Care, Hospice & Advance Care Planning 14.7 Chronic Wounds, Nutrition, Swallowing, Constipation & Hip Fracture 14.8 Sensory Impairment, Dizziness, Elder Mistreatment & Care Settings
16 Chapter 15: Allergy & Immunology (2% of Exam)
15.1 Anaphylaxis: Recognition & Emergency Management 15.2 Urticaria & Angioedema 15.3 Drug Allergy, Desensitization & Adult Immunodeficiency 15.4 Food Allergy, Insect Venom Hypersensitivity, Serum Sickness & Contrast Reactions 15.5 Rhinitis, Conjunctivitis, Eosinophilic & Mast Cell Disorders
17 Chapter 16: Preventive Medicine, Immunization & Clinical Epidemiology
16.1 The USPSTF Framework & Evidence-Based Cancer Screening 16.2 Cardiovascular & Metabolic Screening and Primary Prevention 16.3 Adult Immunization & Vaccines in Special Populations 16.4 Clinical Epidemiology, Biostatistics & Study Design
18 Chapter 17: Miscellaneous - Ethics, Patient Safety & Quality Improvement (2% of Exam)
17.1 Principles of Bioethics & Decisional Capacity 17.2 Informed Consent, Treatment Refusal & Special Scenarios 17.3 Surrogate Decision-Making, Advance Directives & Confidentiality 17.4 Patient Safety Science, Medical Error & Diagnostic Reasoning 17.5 Quality Improvement Methods, Health Disparities & Health Equity
19 Chapter 18: Perioperative Medicine & Medical Consultation
18.1 Preoperative Cardiovascular Risk Assessment 18.2 Preoperative Pulmonary Risk & Perioperative Medication Management 18.3 Perioperative Anticoagulation, Bridging & Postoperative Complications
20 Chapter 19: Ophthalmology (1% of Exam)
19.1 The Acute Red Eye & Ophthalmic Emergencies 19.2 Painless Vision Loss & Chronic Ophthalmic Disease 19.3 Uveitis, Scleritis & Orbital Disease
21 Chapter 20: Otolaryngology & Dental Medicine (1% of Exam)
20.1 Dizziness, Vertigo & Epistaxis 20.2 Ear Disorders, Hearing Loss & Upper Respiratory Infections 20.3 Oral Cavity, Salivary Gland, Laryngeal & Taste and Smell Disorders
17.4 Patient Safety Science, Medical Error & Diagnostic Reasoning
Key Takeaways Explain This Topic AI
Primarily safety and quality improvement is an enumerated subsection of the Miscellaneous blueprint category, and patient safety is also a cross-content area.
The Swiss cheese model describes how latent system failures align with active errors to produce harm.
A just culture distinguishes human error and at-risk behavior, which are managed by system redesign, from reckless behavior, which warrants accountability.
Root cause analysis is a retrospective systems investigation, whereas failure mode and effects analysis is prospective.
Anchoring, premature closure, availability and confirmation bias are the cognitive contributors most often implicated in diagnostic error.
Last updated: August 2026
Patient safety, quality improvement (QI) science, diagnostic error mitigation, and health equity have become core pillars of modern internal medicine practice and high-yield components of the ABIM Board Examination. Internists must be proficient in analyzing medical errors using systems-based frameworks, leading iterative quality improvement initiatives, recognizing cognitive biases in clinical reasoning, and addressing systemic healthcare disparities and social determinants of health.
- 1. Patient Safety Science & Medical Error Analysis
- A. The Swiss Cheese Model of System Accidents
Developed by cognitive psychologist James Reason, the Swiss Cheese Model posits that complex socio-technical systems (such as hospitals) possess multiple defensive layers (e.g., electronic prescribing checks, barcode scanning, nursing double-checks, clinical protocols). Each layer has inherent vulnerabilities or "holes":
Latent Failures (Systemic Vulnerabilities): Underlying weaknesses in organizational structure, management decisions, staffing levels, physical environment, equipment design, or EHR software interfaces. Latent failures lie dormant within the system for long periods without causing immediate harm.
Active Failures (Frontline Unsafe Acts): Errors, slips (unintentional action lapses), mistakes (flawed rule application), or protocol deviations committed by frontline healthcare workers at the sharp end of patient care.
System Accident: Adverse events occur only when the "holes" in every defensive barrier temporarily align, allowing a hazard to pass through all defenses and inflict patient injury. Modern patient safety focuses on strengthening defensive barriers and fixing latent system flaws rather than blaming individual frontline workers .
B. The Just Culture Framework
A Just Culture fosters an open, non-punitive reporting environment while maintaining individual professional accountability by distinguishing among three distinct behavioral categories: Just Culture Behavioral Classification
- │
- ┌────────────────────────────────────────┼────────────────────────────────────────┐
- ▼ ▼ ▼
- Human Error At-Risk Behavior Reckless Behavior
- (Inadvertent Slip/Lapse) (Shortcut / Normalized Risk) (Conscious Disregard of Risk)
- │ │ │
- ▼ ▼ ▼
- Console the clinician • Coach the clinician • Disciplinary / administrative
- Redesign system & defenses • Remove behavioral incentives action
- Fix underlying latent flaws for taking shortcuts • Remedial retraining / sanction
Human Error (Inadvertent Slip or Lapse): An unintentional mistake made while executing a task (e.g., misreading a confusing drug label with identical font, keying in an incorrect digit on an infusion pump). Management response: Console the clinician, investigate latent system factors, and redesign process defenses .
At-Risk Behavior (Choice Where Risk is Believed Negligible): A behavioral choice where a clinician takes a shortcut or bypasses a safety rule, believing the risk is minor or justified to increase efficiency (e.g., pre-signing verbal orders, silencing a monitor alarm without checking the patient, overriding electronic medication warnings routinely). Management response: Coach the clinician, address system workflow bottlenecks that incentivize shortcuts, and increase situational risk awareness .
Reckless Behavior (Conscious Disregard of Substantial/Unjustifiable Risk): A deliberate behavioral choice to disregard a substantial, significant, and unjustifiable risk (e.g., performing a procedure while intoxicated, deliberately falsifying medical records, refusing to perform mandatory surgical timeouts). Management response: Immediate disciplinary action, remedial sanction, and administrative accountability .
C. Taxonomy of Medical Errors & Events
Adverse Event: An injury or harm caused by medical management rather than by the patient's underlying disease process. Adverse events can be preventable (due to medical error) or non-preventable (e.g., an unexpected severe anaphylactic reaction to a first-time antibiotic dose in a patient with no prior drug allergies).
Near Miss ("Good Catch"): A patient safety event or error that had the potential to cause injury but was intercepted and prevented from reaching the patient (e.g., a pharmacy technician draws up the wrong insulin formulation, but the unit nurse discovers the error during barcode verification before administration).
Sentinel Event: A patient safety event (unrelated to the natural course of the patient's illness) that reaches a patient and results in death, permanent harm, or severe temporary harm (e.g., wrong-site surgery, retained surgical foreign object, ABO-incompatible hemolytic transfusion reaction, inpatient suicide, maternal death during labor/delivery, medication overdose causing cardiac arrest). Sentinel events require an immediate Root Cause Analysis (RCA) and voluntary reporting to The Joint Commission (TJC) within 45 days.
D. Root Cause Analysis (RCA) vs. Failure Mode and Effects Analysis (FMEA)
Feature Root Cause Analysis (RCA) Failure Mode and Effects Analysis (FMEA)
Approach Retrospective (performed after a sentinel event or adverse event has occurred). Prospective (performed before implementing a new process, technology, or high-risk drug protocol).
Primary Objective Identify underlying latent system vulnerabilities and causal pathways that led to the event. Identify all potential points of system failure and establish safeguards before harm can occur.
Team Composition Interprofessional team (physicians, nurses, pharmacists, risk managers, frontline staff); non-punitive. Multidisciplinary team representing all stakeholders involved in the new process.
Analytical Tools • "5 Whys" Technique: Iterative questioning drilling down past human error to organizational roots.; • Ishikawa (Fishbone) Diagram: Categorizing causes under People, Process, Equipment, Environment, Materials, Management. • Process mapping / flowcharts.; • Calculating Risk Priority Numbers (RPN) = Severity (S) × Occurrence (O) × Detection (D).
Output / Outcome Actionable Risk Reduction Plan with assigned owners, timelines, and measurable outcome audit metrics. Prioritized list of high-risk failure modes and targeted pre-implementation redesign safeguards.
E. Ethical and Open Disclosure of Medical Errors
When a medical error results in patient harm, healthcare providers have a strict ethical and legal obligation to disclose the error fully and transparently.
Key Communication Principles:
Disclose promptly in a quiet, private setting with the patient and chosen family members present.
Provide a clear, truthful, and factual description of what occurred using plain language without medical jargon.
Express sincere empathy and regret ( "I am deeply sorry that this complication happened to you" ). Note: Sincere apologies of empathy are protected from being used as admissions of legal liability under "Apology Laws" in most US jurisdictions.
Explain the immediate clinical interventions undertaken to mitigate and treat the harm.
Outline the institutional steps and system investigations underway to prevent future recurrence for other patients.
Introduce the CANDOR (Communication and Optimal Resolution) pathway for fair financial resolution and emotional support.
Loading diagram... Institute for Healthcare Improvement (IHI) Model for Improvement & PDSA Architecture
2. Cognitive Biases & Diagnostic Error Reduction
Diagnostic errors contribute to approximately 10% of patient deaths and the majority of medical malpractice claims. Cognitive biases and flawed heuristic thinking represent the primary root causes of diagnostic failure.
A. Major Cognitive Biases Tested on Board Examinations
Cognitive Bias Definition & Mechanism Clinical Scenario / Vignette Example
Anchoring Bias The tendency to fixate on initial clinical data or a preliminary diagnostic impression and fail to adjust the differential diagnosis in light of subsequent contradictory information. Focusing on a history of heavy smoking and treating a patient for COPD exacerbation while ignoring new leg swelling, S3 gallop, and elevated BNP that indicate acute decompensated heart failure.
Premature Closure The tendency to accept a preliminary diagnosis before it is fully verified , abruptly stopping the diagnostic workup. Single most common cognitive error leading to missed diagnoses. Diagnosing a febrile patient with viral gastroenteritis based on nausea and diarrhea without performing a physical exam or recognizing signs of acute pelvic appendicitis.
Availability Heuristic Judging the likelihood of a disease based on how easily recent, vivid, or memorable cases come to mind , leading to overestimating the probability of rare conditions. Ordering extensive workup for pheochromocytoma in every patient with mild palpitations because the physician diagnosed a rare pheochromocytoma the preceding week.
Confirmation Bias Actively seeking or overweighting clinical evidence that supports a favored hypothesis while ignoring, downplaying, or rationalizing away disconfirming evidence. Believing a patient has pulmonary embolism and focusing on sinus tachycardia while ignoring a clear focal consolidation and leukocytosis consistent with lobar pneumonia.
Framing Effect Allowing diagnostic reasoning to be distorted by the way clinical information is presented , contextualized, or labeled by referring clinicians or triage notes. Assuming a patient presenting with acute epigastric pain is suffering from alcohol withdrawal or gastritis because the triage note prominently labels the patient as "homeless alcoholic."
Diagnostic Momentum Uncritically accepting a diagnostic label established by prior healthcare providers and carrying it forward through the chart without re-evaluating primary data. Continuing to treat a patient for "refractory cellulitis" with broad-spectrum IV antibiotics for 2 weeks when re-examination reveals bilateral symmetric edema and stasis dermatitis.
Representativeness Heuristic Judging the probability of an illness based purely on its resemblance to a classic textbook prototype , while ignoring epidemiological base rates. Assuming a 22-year-old female with pleuritic chest pain and normal ECG has pleurisy, failing to evaluate for pulmonary embolism because she does not fit the "typical demographic."
B. Metacognitive Strategies to Prevent Diagnostic Errors
Diagnostic Timeouts: Pausing during clinical encounters or rounds to ask: "What else could this be?" , "What is the worst-case scenario that I cannot afford to miss?" , and "Do any findings contradict my current diagnosis?"
Metacognition ("Reflective Practice"): Consciously stepping back to monitor one's own internal cognitive processes and identifying when emotional exhaustion, sleep deprivation, or anchoring are distorting clinical judgment.
Standardized Diagnostic Checklists: Applying standardized clinical decision rules (e.g., Wells criteria for DVT/PE, PERC rule, Ottawa ankle rules) and red-flag checklists for high-risk presentations (acute headache, chest pain, acute back pain in cancer patients).